Moleculin Biotechincis A Phase 3 Clinical Stage Pharmaceutical Company Based In Houstontexasthe Company Focuses On Developing Therapies For Hard To Treat Tumors And Viral Infectionswith An Emphasis On Innovative Oncology Solutions For Cancers That Are Resistant To Existing Treatments Moleculin S Lead Programannamycinis A Next Generation Anthracycline Designed To Address Multidrug Resistance And Reduce Cardiotoxicitythe Company Is Preparing For A Pivotal Phase 3 Trialknown As Miraclewhich Will Evaluate Annamycin In Combination With Cytarabine For Patients With Relapsed Refractory Acute Myeloid Leukemiaaml In Addition To Annamycinmoleculin Is Advancing Other Candidates Like Wp1066Targeting Brain Tumors And Pancreatic Cancerand Wp1122Which Focuses On Viral Infections And Certain Cancersthe Company Is Committed To Addressing Unmet Medical Needs And Exploring Combination Therapies To Enhance Treatment Efficacy
No conferences found for this company.
| Company Name | Moleculin Biotech Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
